Clinical Trial

PROGAIN Trial in Gastric Cancer Surgery

Study acronym: PROGAIN
Recruiting Phase 3
View on ClinicalTrials.gov →
Summary
This randomized study will evaluate whether protein-enriched parenteral nutrition improves early postoperative recovery in patients undergoing gastrectomy for gastric cancer. Participants will be assigned to receive either protein-enriched parenteral nutrition or standard parenteral nutrition during the perioperative period. The primary outcome is nitrogen balance on postoperative day 5. Secondary outcomes include postoperative complications, recovery of oral intake, and short-term changes in nutritional status and body composition.
Protocol Amendment History 1 change
notable Enrollment increased: 100 -> 110 participants 2026-05-20
Trial Details
NCT Number NCT07488611
Lead Sponsor Soonchunhyang University Hospital
Collaborators: JW Pharmaceutical
Conditions Stomach (Gastric) Cancer
Enrollment 110 participants
Start Date 2026-02-13
Primary Completion 2027-02 (estimated)
Study Completion 2028-03 (estimated)
Updated on ClinicalTrials.gov 2026-05-19